NIH-funded research R01 grant

Linking in utero exposures to midlife brain health and Alzheimer's risk

Official title: Association of the in Utero Exposome with Life-Course Cognition and Prodromal Alzheimer's Disease in Midlife

Funded at Public Health Institute · NIH-11385307 · Data updated 2026-11-12

Researchers are studying how environmental exposures before birth may affect thinking skills in midlife and support early signs of Alzheimer's risk.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPublic Health Institute
NIH-funded
Lab location1 site (Oakland, United States)
Project startSeptember 20, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$684,397
NIH project number5R01NS130713-03
Project IDNIH-11385307 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with documented prenatal or early-life exposure data who are now in midlife and have risk factors for Alzheimer's disease.

Less likely to help

Individuals without midlife biomarker data or those not at risk for Alzheimer's may see limited direct benefit.

What this research studies

This project follows a long-term birth cohort to see if exposure to environmental toxicants before birth is linked to cognitive changes in midlife and early Alzheimer’s biomarkers. It uses metabolomics and blood biomarker analyses to identify signals that precede cognitive decline. The study builds on decades of data from mothers and children, testing pathways that connect early exposures to later brain health. If successful, these findings could point to new windows for preventing cognitive decline before symptoms appear.

Why it matters

Potential benefit: Could lead to early detection markers and prevention strategies for Alzheimer's risk starting from birth or adolescence.

How similar studies have gone: Prior work has linked metabolic changes and glutathione pathways to cognitive decline, supporting the potential relevance of these biomarkers.

Where this research is happening

  • Public Health Institute
    Oakland, United States
    Active

Researchers

  • Principal investigator: Cohn, Barbara a — Public Health Institute
  • Study coordinator: Cohn, Barbara a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.